High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients.

Kashif AsgharIftikhar Ali RanaMuhammad AbubakarKinza HashamMuhammad TahseenSundus BilalShafqat MehmoodAsim FarooqKashif SiddiqueAsif Loya

Published in: Asian Pacific journal of cancer prevention : APJCP (2023)

Our data showed that expression of IDO along with Bin1 expression could be investigated for clinical evaluation in HCC. IDO might be used as an immunotherapeutic target for HCC. Therefore, further studies in larger patient cohorts are warranted.

Keyphrases

poor prognosis
end stage renal disease
binding protein
clinical evaluation
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
patient reported outcomes
electronic health record
high resolution